NVAX profile · all as-reported value updates
NOVAVAX INC (NVAX) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2017 | -138,696,000 | -144,476,000 | -5,780,000 | -4.00% | revised comparative figure | 0001144204-18-014686 0001104659-20-031944 | 3 filed observations examined for this concept and period. |
| Operating cash flow | 2016 | -255,467,000 | -258,768,000 | -3,301,000 | -1.28% | revised comparative figure | 0001144204-18-014686 0001144204-19-014640 | 2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing. |